Machine learning-based biomarker screening for acute myeloid leukemia prognosis and therapy from diverse cell-death patterns.

{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:39090256", "kind": "science-record", "revision": 4, "content_hash": "sha256:b09f358e03573b9d1148fd649b834b320878523898ccb805ba801db2acbe1373", "created_at": "2026-11-01T20:29:10Z", "updated_at": "2026-11-01T22:54:49Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Machine learning-based biomarker screening for acute myeloid leukemia prognosis and therapy from diverse cell-death patterns.", "doi": "10.1038/s41598-024-68755-3", "pmid": "39090256", "authors": ["Yu Qin", "Xuexue Pu", "Dingtao Hu", "Mingzhen Yang"], "journal": "Scientific reports", "year": 2024, "abstract": "Acute myeloid leukemia (AML) exhibits pronounced heterogeneity and chemotherapy resistance. Aberrant programmed cell death (PCD) implicated in AML pathogenesis suggests PCD-related signatures could serve as biomarkers to predict clinical outcomes and drug response. We utilized 13 PCD pathways, including apoptosis, pyroptosis, ferroptosis, autophagy, necroptosis, cuproptosis, parthanatos, entotic cell death, netotic cell death, lysosome-dependent cell death, alkaliptosis, oxeiptosis, and disulfidptosis to develop predictive models based on 73 machine learning combinations from 10 algorithms. Bulk RNA-sequencing, single-cell RNA-sequencing transcriptomic data, and matched clinicopathological information were obtained from the TCGA-AML, Tyner, and GSE37642-GPL96 cohorts. These datasets were leveraged to construct and validate the models. Additionally, in vitro experiments were conducted to substantiate the bioinformatics findings. The machine learning approach established a 6-gene pan-programmed cell death-related genes index (PPCDI) signature. Validation in two external cohorts showed high PPCDI associated with worse prognosis in AML patients. Incorporating PPCDI with clinical variables, we constructed several robust prognostic nomograms that accurately predicted prognosis of AML patients. Multi-omics analysis integrating bulk and single-cell transcriptomics revealed correlations between PPCDI and immunological features, delineating the immune microenvironment landscape in AML. Patients with high PPCDI exhibited resistance to conventional chemotherapy like doxorubicin but retained sensitivity to dasatinib and methotrexate (FDA-approved drugs for other leukemias), suggesting the potential of PPCDI to guide personalized therapy selection in AML. In summary, we developed a novel PPCDI model through comprehensive analysis of diverse programmed cell death pathways. This PPCDI signature demonstrates great potential in predicting clinical prognosis and drug sensitivity phenotypes in AML patients.", "claims": [{"id": "claim-data-access", "statement": "RNA sequencing (RNA-seq) expression data (log2 transformed) were obtained for 129 AML patients from The Cancer Genome Atlas (TCGA) database (https://portal.gdc.com).", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:39090256", "locator": "sections[3] \"Data acquisition and preprocessing\" paragraph 2", "quote": "RNA sequencing (RNA-seq) expression data (log2 transformed) were obtained for 129 AML patients from The Cancer Genome Atlas (TCGA) database (https://portal.gdc.com)."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:39090256"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE185993"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE185993"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:39090256", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1038/s41598-024-68755-3", "sha256": "sha256:faf9d5ee1a3304c369cbeadb1e831db55a8e88de16aa896c1333f42da1912d83", "bytes": 41733, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1038/s41598-024-68755-3", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC11294352", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE185993", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE185993", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE185993", "version": null, "note": "RNA sequencing (RNA-seq) expression data (log2 transformed) were obtained for 129 AML patients from The Cancer Genome Atlas (TCGA) database (https://portal.gdc.com).", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "RNA sequencing (RNA-seq) expression data (log2 transformed) were obtained for 129 AML patients from The Cancer Genome Atlas (TCGA) database (https://portal.gdc.com).", "access_statement_kind": "repository_route_statement", "sample_accessions": ["GSM5624246", "GSM5624247", "GSM5624248", "GSM5624249", "GSM5624250", "GSM5624251", "GSM5624252", "GSM5624253", "GSM5624254", "GSM5624255", "GSM5624256", "GSM5624257", "GSM5624258", "GSM5624259", "GSM5624260", "GSM5624261", "GSM5624262", "GSM5624263", "GSM5624264", "GSM5624265", "GSM5624266", "GSM5624267", "GSM5624268", "GSM5624269", "GSM5624270", "GSM5624271", "GSM5624272", "GSM5624273", "GSM5624274", "GSM5624275", "GSM5624276", "GSM5624277", "GSM5624278", "GSM5624279", "GSM5624280", "GSM5624281", "GSM5624282", "GSM5624283", "GSM5624284", "GSM5624285", "GSM5624286", "GSM5624287", "GSM5624288", "GSM5624289", "GSM5624290", "GSM5624291", "GSM5624292", "GSM5624293", "GSM5624294", "GSM5624295", "GSM5624296", "GSM5624297", "GSM5624298", "GSM5624299", "GSM5624300", "GSM5624301", "GSM5624302", "GSM5624303", "GSM5624304", "GSM5624305", "GSM5624306", "GSM5624307", "GSM5624308", "GSM5624309", "GSM5624376", "GSM5624377", "GSM5624378", "GSM5624379", "GSM5624380", "GSM5624381", "GSM5624382", "GSM5624383", "GSM5624384", "GSM5624385", "GSM5624386", "GSM5624387", "GSM5624388", "GSM5624389", "GSM5624390", "GSM5624391", "GSM5628163", "GSM5628164", "GSM5628165", "GSM5628166", "GSM5628167", "GSM5628168", "GSM5628169", "GSM5628170", "GSM5628171", "GSM5628172", "GSM5628173", "GSM5628174", "GSM5628175", "GSM5628176", "GSM5628177", "GSM5628178", "GSM5628179", "GSM5628180", "GSM5628181", "GSM5628182", "GSM5628183", "GSM5628184", "GSM5628185", "GSM5628186", "GSM5628187", "GSM5628188", "GSM5628189", "GSM5628190", "GSM5628191", "GSM5628192", "GSM5628195", "GSM5628196", "GSM5628197", "GSM6412447", "GSM6412448", "GSM6412449", "GSM6412450", "GSM6412451", "GSM6412452", "GSM6412453", "GSM6412454", "GSM6412455"], "sample_count": 122, "group_sizes": null, "group_sizes_basis": null, "platform": "21697;18573;24676", "taxon": "Homo sapiens", "title": "Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia", "resolution_checked_at": "2026-11-01T20:16:08Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}], "gaps": ["asset:data:geo:GSE185993 not downloaded", "asset:data:geo:GSE185993 licence not read"]}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": "survival_analysis", "specific": "cox_proportional_hazards", "label": "Survival analysis", "dsl_operations": ["cox_ph"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 1.0, "band": "reordered", "quote": "Differential expression analysis was conducted comparing deceased and surviving AML patients across the three datasets using the limma package. A total of 73 algorithm combinations were evaluated. To develop a robust PPCDS signature with optimal stability, the 73 models were trained in a leave-one-out cross-validation (LOOCV) framework27. Model performance was assessed using the concordance index (c-index), from which the final optimal algorithm combination was selected."}}, {"id": "method-2", "family": "group_comparison", "specific": "wilcoxon", "label": "Group comparison", "dsl_operations": [], "missing_operations": ["group_comparison_wilcoxon"], "expressible": false, "parameters": {}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 0.8, "band": "high", "quote": "Wilcoxon"}}, {"id": "method-3", "family": "group_comparison", "specific": "anova", "label": "Group comparison", "dsl_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 0.8, "band": "high", "quote": "analysis of variance"}}, {"id": "method-4", "family": "survival_analysis", "specific": "kaplan_meier", "label": "Survival analysis", "dsl_operations": ["survival_km"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.8, "band": "high", "quote": "Kaplan-Meier"}}, {"id": "method-5", "family": "differential_expression", "specific": "limma_voom", "label": "Differential expression analysis", "dsl_operations": ["normalise_counts", "differential_expression_fit", "fdr_bh"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["count_matrix_with_condition"], "evidence": {"score": 0.8, "band": "high", "quote": "limma"}}], "targets": [], "gaps": ["method.reader_differs_from_extractor"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["cox_ph"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: cox_proportional_hazards."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE37642-GPL96", "GSE185993"], "resolved_accessions": ["GSE185993"], "statements": ["RNA sequencing (RNA-seq) expression data (log2 transformed) were obtained for 129 AML patients from The Cancer Genome Atlas (TCGA) database (https://portal.gdc.com)."], "basis": "The paper names GSE185993 in GEO and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["cox_ph"], "assets": ["source:pmid:39090256", "data:geo:GSE185993"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE185993"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-11-01T19:26:13Z", "independence": "single_reader"}, "evidence_check": {"method": "reordered", "availability": null}, "calls": 5, "usage": {"prompt_tokens": 11197, "completion_tokens": 2601, "cached_tokens": 264}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:39090256", "type": "paper", "label": "pmid:39090256"}, {"id": "source:pmid:39090256", "type": "manuscript", "label": "PMID 39090256 full text"}, {"id": "data:geo:GSE185993", "type": "dataset", "label": "GEO GSE185993"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:39090256", "type": "paper", "label": "pmid:39090256"}, {"id": "source:pmid:39090256", "type": "manuscript", "label": "PMID 39090256 full text"}, {"id": "data:geo:GSE185993", "type": "dataset", "label": "GEO GSE185993"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-39090256", "type": "extraction", "used": ["source:pmid:39090256"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE185993", "type": "accession_resolution", "used": ["data:geo:GSE185993"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:39090256", "parent_hash": "sha256:c8299c6bc3dde97f9cb3b7396dd43313e80c15110e90631e890eba12982179ab", "fork_of": null, "generation": 3}, "gaps": ["asset:data:geo:GSE185993 licence not read", "asset:data:geo:GSE185993 not downloaded", "execution.not_run", "method.reader_differs_from_extractor", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "apoptosis_assay", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.69, "evidence": ["onse. We utilized 13 PCD pathways, including apoptosis, pyroptosis, ferroptosis, autophagy, necropt"], "order_basis": "paper_text_order:386", "id": "assay:1"}, {"role": "data_generation", "definition_id": "rna_seq", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["arning combinations from 10 algorithms. Bulk RNA-sequencing, single-cell RNA-sequencing transcriptomic d", "algorithms. Bulk RNA-sequencing, single-cell RNA-sequencing transcriptomic data, and matched clinicopath", "k RNA-sequencing, single-cell RNA-sequencing transcriptomic data, and matched clinicopathological inform", "cs analysis integrating bulk and single-cell transcriptomics revealed correlations between PPCDI and immu"], "order_basis": "paper_text_order:684", "id": "assay:2"}, {"role": "data_generation", "definition_id": "scrna_seq", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "unsupported", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.93, "evidence": ["s. Multi-omics analysis integrating bulk and single-cell transcriptomics revealed correlations between PPCDI and immu"], "order_basis": "paper_text_order:1432", "id": "assay:3"}, {"role": "analysis", "definition_id": "survival_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["cox_ph"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["Differential expression analysis was conducted comparing deceased and surviving AML patients across the three datasets using the limma package. A total of 73 algorithm combinations were evaluated. To develop a robust PPCDS signature with optimal stability, the 73 models were trained in a leave-one-out cross-validation (LOOCV) framework27. Model performance was assessed using the concordance index (c-index), from which the final optimal algorithm combination was selected."], "order_basis": "consumes_earlier_output", "id": "assay:4"}]}